120 related articles for article (PubMed ID: 16822278)
1. Effect of voriconazole on the pharmacokinetics and pharmacodynamics of zolpidem in healthy subjects.
Saari TI; Laine K; Leino K; Valtonen M; Neuvonen PJ; Olkkola KT
Br J Clin Pharmacol; 2007 Jan; 63(1):116-20. PubMed ID: 16822278
[TBL] [Abstract][Full Text] [Related]
2. Voriconazole and fluconazole increase the exposure to oral diazepam.
Saari TI; Laine K; Bertilsson L; Neuvonen PJ; Olkkola KT
Eur J Clin Pharmacol; 2007 Oct; 63(10):941-9. PubMed ID: 17676319
[TBL] [Abstract][Full Text] [Related]
3. Effects of the antifungals voriconazole and fluconazole on the pharmacokinetics of s-(+)- and R-(-)-Ibuprofen.
Hynninen VV; Olkkola KT; Leino K; Lundgren S; Neuvonen PJ; Rane A; Valtonen M; Vyyryläinen H; Laine K
Antimicrob Agents Chemother; 2006 Jun; 50(6):1967-72. PubMed ID: 16723553
[TBL] [Abstract][Full Text] [Related]
4. Effect of voriconazole on the pharmacokinetics and pharmacodynamics of intravenous and oral midazolam.
Saari TI; Laine K; Leino K; Valtonen M; Neuvonen PJ; Olkkola KT
Clin Pharmacol Ther; 2006 Apr; 79(4):362-70. PubMed ID: 16580904
[TBL] [Abstract][Full Text] [Related]
5. Effect of voriconazole on the pharmacokinetics of diclofenac.
Hynninen VV; Olkkola KT; Leino K; Lundgren S; Neuvonen PJ; Rane A; Valtonen M; Laine K
Fundam Clin Pharmacol; 2007 Dec; 21(6):651-6. PubMed ID: 18034666
[TBL] [Abstract][Full Text] [Related]
6. Rifampin reduces plasma concentrations and effects of zolpidem.
Villikka K; Kivistö KT; Luurila H; Neuvonen PJ
Clin Pharmacol Ther; 1997 Dec; 62(6):629-34. PubMed ID: 9433391
[TBL] [Abstract][Full Text] [Related]
7. Voriconazole, but not terbinafine, markedly reduces alfentanil clearance and prolongs its half-life.
Saari TI; Laine K; Leino K; Valtonen M; Neuvonen PJ; Olkkola KT
Clin Pharmacol Ther; 2006 Nov; 80(5):502-8. PubMed ID: 17112806
[TBL] [Abstract][Full Text] [Related]
8. Voriconazole drastically increases exposure to oral oxycodone.
Hagelberg NM; Nieminen TH; Saari TI; Neuvonen M; Neuvonen PJ; Laine K; Olkkola KT
Eur J Clin Pharmacol; 2009 Mar; 65(3):263-71. PubMed ID: 18836708
[TBL] [Abstract][Full Text] [Related]
9. Effect of itraconazole on the pharmacokinetics and pharmacodynamics of zolpidem.
Luurila H; Kivistö KT; Neuvonen PJ
Eur J Clin Pharmacol; 1998 Apr; 54(2):163-6. PubMed ID: 9626922
[TBL] [Abstract][Full Text] [Related]
10. Gender differences in pharmacokinetics and pharmacodynamics of zolpidem following sublingual administration.
Greenblatt DJ; Harmatz JS; Singh NN; Steinberg F; Roth T; Moline ML; Harris SC; Kapil RP
J Clin Pharmacol; 2014 Mar; 54(3):282-90. PubMed ID: 24203450
[TBL] [Abstract][Full Text] [Related]
11. Effect of voriconazole on the pharmacokinetics of cyclosporine in renal transplant patients.
Romero AJ; Le Pogamp P; Nilsson LG; Wood N
Clin Pharmacol Ther; 2002 Apr; 71(4):226-34. PubMed ID: 11956505
[TBL] [Abstract][Full Text] [Related]
12. Voriconazole increases while itraconazole decreases plasma meloxicam concentrations.
Hynninen VV; Olkkola KT; Bertilsson L; Kurkinen KJ; Korhonen T; Neuvonen PJ; Laine K
Antimicrob Agents Chemother; 2009 Feb; 53(2):587-92. PubMed ID: 19015346
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and pharmacodynamics of zolpidem after oral administration of a single dose in dogs.
Giorgi M; Portela DA; Breghi G; Briganti A
Am J Vet Res; 2012 Oct; 73(10):1650-6. PubMed ID: 23013193
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic interaction between zolpidem and carbamazepine in healthy volunteers.
Vlase L; Popa A; Neag M; Muntean D; Bâldea I; Leucuţa SE
J Clin Pharmacol; 2011 Aug; 51(8):1233-6. PubMed ID: 21098143
[TBL] [Abstract][Full Text] [Related]
15. Voriconazole more likely than posaconazole increases plasma exposure to sublingual buprenorphine causing a risk of a clinically important interaction.
Fihlman M; Hemmilä T; Hagelberg NM; Kuusniemi K; Backman JT; Laitila J; Laine K; Neuvonen PJ; Olkkola KT; Saari TI
Eur J Clin Pharmacol; 2016 Nov; 72(11):1363-1371. PubMed ID: 27510521
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics, pharmacodynamics, and relative pharmacokinetic/pharmacodynamic profiles of zaleplon and zolpidem.
Drover D; Lemmens H; Naidu S; Cevallos W; Darwish M; Stanski D
Clin Ther; 2000 Dec; 22(12):1443-61. PubMed ID: 11192136
[TBL] [Abstract][Full Text] [Related]
17. Kinetic and dynamic interaction study of zolpidem with ketoconazole, itraconazole, and fluconazole.
Greenblatt DJ; von Moltke LL; Harmatz JS; Mertzanis P; Graf JA; Durol AL; Counihan M; Roth-Schechter B; Shader RI
Clin Pharmacol Ther; 1998 Dec; 64(6):661-71. PubMed ID: 9871431
[TBL] [Abstract][Full Text] [Related]
18. Short-term clarithromycin administration impairs clearance and enhances pharmacodynamic effects of trazodone but not of zolpidem.
Farkas D; Volak LP; Harmatz JS; von Moltke LL; Court MH; Greenblatt DJ
Clin Pharmacol Ther; 2009 Jun; 85(6):644-50. PubMed ID: 19242403
[TBL] [Abstract][Full Text] [Related]
19. The effect of ingestion time interval on the interaction between itraconazole and triazolam.
Neuvonen PJ; Varhe A; Olkkola KT
Clin Pharmacol Ther; 1996 Sep; 60(3):326-31. PubMed ID: 8841155
[TBL] [Abstract][Full Text] [Related]
20. Comparative pharmacokinetics of voriconazole administered orally as either crushed or whole tablets.
Dodds Ashley ES; Zaas AK; Fang AF; Damle B; Perfect JR
Antimicrob Agents Chemother; 2007 Mar; 51(3):877-80. PubMed ID: 17145785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
